• Xtandi Does Not Increase Seizure Rates in At-Risk mCRPC Patients, Study Finds
  • 20 Things Men with Prostate Cancer Wish Healthy Friends, Family Knew
  • Researchers Identify Potential Therapeutic Target for Advanced Prostate Cancer
  • PET Scans Help Identify Certain PC Patients Who May Benefit from Salvage Radiation Therapy
  • Rutgers Researcher Awarded $954,000 for Work on Prostate Cancer Hormone Therapy Xtandi
  • Researchers Link Aggressiveness of Prostate Cancer to Process of RB Gene Loss
  • 7 Things to Do When the Misery of Cancer Won’t End
  • Shorter but Higher-dose Radiation Course Cuts Risk of Prostate Cancer Returning, Study Finds
  • Safety Concerns Make Bayer Unblind Prostate Cancer Trial of Xofigo Combination
  • ZERO and Perthera Launch ‘Decode Your Prostate Cancer’ Program
  • Researchers to Examine Link Between Battlefield Chemical Exposure and Prostate Cancer
  • Prostate Cancer Often Deadly for Urban American Indians and Alaskan Natives, Study Shows